Parkinson's Foundation kicks off genetic testing program

By staff writers

July 16, 2019 -- The Parkinson's Foundation is offering free genetic testing and counseling for U.S. patients with Parkinson's disease through a partnership with Fulgent Genetics, in a bid to improve the precision of diagnosis and accelerate the development of new treatments.

The program -- dubbed PD GENEration -- will kick off at Columbia University Irving Medical Center, but other pilot sites will come on board later. Results will be stored and used for research purposes. The plan is to initially offer the testing program to 600 participants, and later roll it out to U.S. 50 centers by 2020; the foundation's long-term aim is to include 15,000 Parkinson's patients.

Testing/next-generation sequencing for the program, as well as storage of samples, will be managed by Fulgent Genetics of Temple City, CA. Parkinson's is caused by hereditary anomalies in 10% to 15% of cases. Genetic mutations that have been associated with the disease include leucine-rich repeat kinase 2 (LRRK2), phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1), and glucocerebrosidase (GBA).

AAIC update: Where blood-based dementia tests stand in 2019
Against the shadowy backdrop of multiple failed trials in Alzheimer's disease, hope springs eternal for a reliable, noninvasive blood test for dementia,...
Cerebrospinal fluid test helps pinpoint dementia disorders
Testing for neurofilament light protein in cerebrospinal fluid appears to be helpful for differentiating some neurological conditions, such as frontotemporal...

Copyright © 2019

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.